CRIS Current Research Information System

LAURIOLA, MATTIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.925
NA - Nord America 4.289
EU - Europa 4.041
SA - Sud America 271
AF - Africa 263
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 1
Totale 13.808
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.223
IT - Italia 1.673
SG - Singapore 1.405
CN - Cina 1.316
VN - Vietnam 1.135
GB - Regno Unito 516
DE - Germania 420
HK - Hong Kong 298
SE - Svezia 297
FR - Francia 213
BR - Brasile 207
IN - India 174
KR - Corea 162
NL - Olanda 151
IE - Irlanda 142
RU - Federazione Russa 119
AT - Austria 111
FI - Finlandia 111
JP - Giappone 91
CI - Costa d'Avorio 89
ZA - Sudafrica 64
UA - Ucraina 57
TG - Togo 56
ID - Indonesia 45
JO - Giordania 45
CA - Canada 42
BG - Bulgaria 40
EE - Estonia 40
TH - Thailandia 35
CH - Svizzera 34
PH - Filippine 33
AR - Argentina 30
MY - Malesia 25
ES - Italia 24
BD - Bangladesh 23
SC - Seychelles 22
PL - Polonia 20
TW - Taiwan 18
AU - Australia 16
IL - Israele 16
IQ - Iraq 16
PK - Pakistan 15
GR - Grecia 14
IR - Iran 14
TR - Turchia 14
MX - Messico 13
DK - Danimarca 11
SA - Arabia Saudita 11
EC - Ecuador 10
RO - Romania 9
UZ - Uzbekistan 9
MA - Marocco 8
AZ - Azerbaigian 7
CZ - Repubblica Ceca 7
PY - Paraguay 7
BE - Belgio 6
CO - Colombia 6
LT - Lituania 6
HR - Croazia 5
NG - Nigeria 5
VE - Venezuela 5
KE - Kenya 4
LB - Libano 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
DZ - Algeria 3
EG - Egitto 3
PE - Perù 3
PT - Portogallo 3
AM - Armenia 2
CM - Camerun 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GH - Ghana 2
JM - Giamaica 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
CL - Cile 1
CU - Cuba 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
JE - Jersey 1
LU - Lussemburgo 1
LV - Lettonia 1
ML - Mali 1
MN - Mongolia 1
MT - Malta 1
NI - Nicaragua 1
RS - Serbia 1
SI - Slovenia 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 13.807
Salva come PNG Salva come JPEG
Città #
Singapore 984
Bologna 717
Ashburn 540
Southend 415
Chandler 354
Fairfield 324
Hefei 323
Hong Kong 269
Ho Chi Minh City 267
Hanoi 253
Houston 235
San Jose 188
Seattle 177
Santa Clara 167
Woodbridge 162
Dublin 139
Seoul 137
Wilmington 135
Cambridge 121
Milan 119
Princeton 117
Beijing 116
Boardman 103
Vienna 100
Dallas 97
Abidjan 89
Lauterbourg 89
Dong Ket 79
Helsinki 77
Ann Arbor 74
Tokyo 72
Council Bluffs 70
Los Angeles 63
Redmond 62
Bremen 58
Nanjing 57
Lomé 56
New York 48
Westminster 46
Amman 45
Berlin 43
Rome 43
São Paulo 42
Da Nang 41
Sofia 40
Munich 39
Frankfurt am Main 38
Haiphong 38
Amsterdam 36
Jakarta 36
Shanghai 35
Padova 34
Modena 33
Bengaluru 31
Buffalo 30
London 29
Guangzhou 26
Nuremberg 26
Bern 25
Jinan 25
Saint Petersburg 25
Redondo Beach 24
Shenyang 24
Turin 22
Florence 21
Naples 21
Chicago 20
Medford 20
Orem 20
Lappeenranta 18
San Diego 18
The Dalles 18
Bangkok 17
Jiaxing 17
Changsha 16
Hải Dương 16
Jacksonville 16
Reggio Emilia 16
Boydton 15
Can Tho 15
Falkenstein 15
Turku 15
Zhengzhou 15
Montreal 14
San Francisco 14
Tianjin 14
Düsseldorf 13
Forlì 13
Kuala Lumpur 13
Olalla 13
Rehovot 13
Thái Nguyên 13
Toronto 13
Xi'an 13
Brescia 12
Warsaw 12
Falls Church 11
Phoenix 11
Wuhan 11
Biên Hòa 10
Totale 8.871
Salva come PNG Salva come JPEG
Nome #
Glucocorticoid receptor antagonization propels endogenous cardiomyocyte proliferation and cardiac regeneration 378
BMP7 promotes cardiomyocyte regeneration in zebrafish and adult mice 299
EGF induces microRNAs that target suppressors of cell migration: miR-15b targets MTSS1 in breast cancer 270
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary 251
Colorectal cancer screening: Assessment of CEACAM6, LGALS4, TSPAN8 and COL1A2 as blood markers in faecal immunochemical test negative subjects 245
Adenomatous polyposis coli (APC) regulates miR17-92 cluster through β-catenin pathway in colorectal cancer 237
Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression 232
Human trisomy 21 fibroblasts rescue methotrexate toxic effect after treatment with 5-methyl-tetrahydrofolate and 5-formyl-tetrahydrofolate 232
IL23R, NOD2/CARD15, ATG16L1 and PHOX2B polymorphisms in a group of patients with Crohn's disease and correlation with sub-phenotypes. 225
A role for epidermal growth factor receptor in idiopathic pulmonary fibrosis onset. 220
Mechanisms of acquired resistance to cetuximab: role of interleukin-1 219
Submicroscopic alterations and gene expression profiles of human colon cancer cell lines in response to cetuximab, gefitinib and EGF 218
IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy 215
Mechanisms of acquired resistance to cetuximab: role of interleukin-1 211
A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib 208
Systematic large-scale meta-analysis identifies a panel of two mRNAs as blood biomarkers for colorectal cancer detection 205
A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy 204
Displayed correlation between gene expression profiles and submicroscopic alterations in response to cetuximab, gefitinib and EGF in human colon cancer cell lines. 202
The EGFR R521K polymorphism influences the risk to develop colorectal cancer. 201
Aberrant MET activation impairs perinuclear actin cap organization with YAP1 cytosolic relocation 200
Modulation of ERBB signaling from tissue homeostasis to cancer progression 198
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies 198
NF-kB oscillation profiles decode response to anti-EGFR monoclonal antibodies 197
Identification by a Digital Gene Expression Displayer (DGED) and test by RT-PCR analysis of new mRNA candidate markers for colorectal cancer in peripheral blood 197
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization 196
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer 194
Microarray-based identification and RT-PCR test screening for epithelial-specific mRNAs in peripheral blood of patients with colon cancer. 194
CEA Cell Adhesion Molecule 6 (CEACAM6), Collagen Type I Alpha 2 Chain (COL1A2), Galectin 4 (LGALS4) and Tetraspanin 8 (TSPAN8) mRNAs as blood biomarkers for colorectal cancer 194
Gene expression profile of human colon cancer cells treated with cross-reacting material 197, a diphtheria toxin non-toxic mutant. 193
Neuregulin 4 Boosts the Efficacy of Anti-ERBB2 Neutralizing Antibodies 190
Mechanisms of acquired resistance to cetuximab: role of interleukin 1 184
The roadmap of colorectal cancer screening 184
The transcription factor CCAAT enhancer-binding protein β protects rat cerebellar granule neurons from apoptosis through its transcription-activating isoforms. 183
PDL1 immunohistochemistry in canine neoplasms: Validation of commercial antibodies, standardization of evaluation, and scoring systems 179
ERBB2 circumvents negative feedback mechanisms induced by EGFR overactivation in basal-like/triple-negative breast cancer cells 175
A putative role for interleukin 1 pathway in resistance to EGFR blockade 170
Fibroblast-associated protein-α expression and BPV nucleic acid distribution in equine sarcoids 170
Estrogen Receptors and Melanoma: A Review 169
Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection 169
Resistance to EGFR Targeting Treatments in Colorectal Cancer 165
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 163
ERBB RECEPTORS DIMERIZATION DEFINES BREAST CANCERS SUBTYPES AND CLINICAL OUTCOMES: IMPLICATION FOR CANCER THERAPIES 163
NRG1/ERBB3/ERBB2 Axis Triggers Anchorage-Independent Growth of Basal-like/Triple-Negative Breast Cancer Cells 161
Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor 160
Molecular mechanisms of resistance to cetuximab mediated by IL-1 signaling 160
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer 158
The R521K polymorphism of EGFR influences the risk of colorectal cancer 155
An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumors 153
A novel role for interleukin 1 axis in the resistance to EGFR targeting antibody 141
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in Consensus Molecular Subtype 1 colon cancer 141
Identification of novel growth factors for cardiac regeneration 137
null 136
qCMA: A Desktop Application for Quantitative Collective Cell Migration Analysis 135
Female melanoma and estrogen receptors expression: an immunohistochemical pilot study 133
MET receptor regulates perinuclear actin cap remodeling through YAP1 inactivation 132
Unveiling the role of interleukine-1 Receptor in response to EGFR blockade 131
Beta-Catenin/HuR Post-Transcriptional Machinery Governs Cancer Stem Cell Features in Response to Hypoxia 131
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab 129
ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma 129
null 128
null 121
null 117
A new method for the study of biophysical and morphological parameters in 3D cell cultures: Evaluation in LoVo spheroids treated with crizotinib 117
IL-1 Associated Post Senescence Reprogramming Impairs Response To EGFR Neutralization 115
Two Phases of Mitogenic Signaling Unveil Roles for p53 and EGR1 in Elimination of Inconsistent Growth Signals 113
SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors 113
Sorcin promotes migration in cancer and regulates the EGF-dependent EGFR signaling pathways 112
Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions 110
A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors 108
Modeling ductal carcinoma in situ: a HER2–Notch3 collaboration enables luminal filling 108
Glucocorticoid Receptor Modulates EGFR Feedback upon Acquisition of Resistance to Monoclonal Antibodies 103
Diurnal suppression of EGFR signalling by glucocorticoids and implications for tumour progression and treatment. 101
LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer-Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result 99
ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation 97
Targeting anaplastic lymphoma kinase in consensus molecular subtype 1 colon cancer patients 90
null 87
MET receptor regulates perinuclear actin cap remodeling through YAP1 inactivation 85
null 82
CIRCADIAN DEPENDENT MOTILITY: THE ROLE FOR THE PERINUCLEAR ACTIN CAP 81
Diagnostic Accuracy of an Add-On, Blood-Based Screening Test for Colorectal Cancer in Two Established Screening Programmes 81
null 81
Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer 78
IL-1 in the microenvironment impairs response to EGFR- neutralization in CRC patients 76
null 74
Developing Comprehensive In Vitro and In Vivo Models: Patient-Derived Organoids (PDOs) and Xenografts (PDXs) for Morphological and Functional Analysis and Drug Screening in Head and Neck Squamous Cell Carcinoma 72
null 72
Development of Head and Neck Squamous Cell Carcinoma Patient-Derived Xenografts (PDXs) and Organoids (PDXOs) for Morphological Analysis and Drug Screening 63
Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progression 54
Circadian dependent motility: the role for the perinuclear actin cap 51
The Multifaceted Role of Growth Differentiation Factor 15 (GDF15): A Narrative Review from Cancer Cachexia to Target Therapy 46
Beyond EGFR inhibition in head and neck squamous cell carcinoma: Overcoming resistance mechanisms and novel therapeutic frontiers 46
Activation of ALK Signaling Pathway Induces DNA Damage Response in Colorectal Cancer 45
IL-1 in the microenvironment impairs response to EGFR- neutralization in CRC patients 45
A humanized anaplastic lymphoma kinase (ALK)-directed antibody-drug conjugate with pyrrolobenzodiazepine payload demonstrates efficacy in ALK-expressing cancers 37
Towards the emerging crosstalk: ERBB family and steroid hormones 29
Harnessing glucocorticoid receptor antagonism to enhance the efficacy of cardiac regenerative growth factors and cytokines 25
Sorcin regulates alveolarization and airway tissue remodeling during lung morphogenesis 22
Totale 14.203
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.210
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.210
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021309 0 0 0 0 0 0 0 0 0 37 61 211
2021/20221.144 71 38 60 57 88 64 32 81 74 81 250 248
2022/20231.788 142 220 101 253 147 135 79 130 306 49 105 121
2023/2024752 59 93 40 75 60 144 40 46 25 75 41 54
2024/20252.582 104 235 225 181 281 147 295 143 85 209 235 442
2025/20265.334 469 584 526 428 516 367 625 198 1.215 406 0 0
Totale 14.203